Login Sign Up Contact Us

Categories

Countries

Request/Offer Detail

Title: Bivalirudin Trifluoroacetate
TypeName: Business Offer
Request Date:2017/06/23
Country: United States
Summary: BG 8967; Hirulog; Hirulog I; Bivalirudin; Angiomax; Hirulog-1; Hirulog1; Hirulog 1; BG8967; BG 8967; BG-8967; LS-172701; LS172701; LS 172701
Description: Bivalirudin is a DTI that overcomes many limitations seen with indirect thrombin inhibitors. It is a short, synthetic peptide that is potent, highly specific, and a reversible inhibitor of thrombin. Bivalirudin inhibits both circulating and clot-bound thrombin, while also inhibiting thrombin-mediated platelet activation and aggregation. It has a quick onset of action and a short half-life, without binding to plasma proteins (other than thrombin) or red blood cells. Therefore it has a predictable antithrombotic response.http://www.creative-peptides.com/product/bivalirudin-trifluoroacetate-item-10-101-06-16.html
Advantages:
Comments:
RequestId: 275
Name:Caroline Miller
Telphone:
Email:contact@creative-peptides.com

Special Business
Yoga King
URBN Dental Uptown
Earth Bikes
Vancouver Demolition
All Seasons Grass
Edulcorantes Hileret

Sponsors
smartportal sponsors